Physician profile
Aaina Kochhar
NPI 1497919195
$10,956.80
in general payments reported to CMS, 2019-2025
8 companies · $1,602 in 2025
The $1,602 reported for 2025 was more than what a typical Clinical Genetics (M.D.) provider received nationally (typical 2025 total: $255).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2021: $30.00 · 2022: $3,630 · 2023: $5,595 · 2025: $1,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $6,285 · Travel and Lodging: $526 · Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $6,285.00 |
| Travel and Lodging | $526.35 |
| Food and Beverage | $385.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $9,209.26 | 2022-2023 | Ravicti |
| Intrabio INC | $1,485.00 | 2025 | Aqneursa |
| Orchard Therapeutics North America | $116.85 | 2025 | Lenmeldy |
| Shire North American Group INC | $53.01 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $30.00 | 2021 | |
| Cycle Pharmaceuticals INC | $23.66 | 2019 | |
| Travere Therapeutics, INC. | $23.34 | 2019 | |
| Biomarin Pharmaceutical INC. | $15.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaina Kochhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.